C. Darke

C. Darke, M. Thomas, J. Street, 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

HLA-A9 antibodies and epitopes.

C. Darke, M. Thomas, J. Street, 1996, Tissue antigens.

Automated routine HLA-B27 typing by flow cytometry.

J. Smith, P. R. Evans, C. Darke, 1996, Journal of immunological methods.

Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].

E. Adams, P. Parham, J. Gumperz, 1995, Tissue antigens.

IMMUNOGENETIC ANALYSIS OF HLA‐DR10 HOMOZYGOUS INDIVIDUALS

C. Darke, N. Young, K. Gibson, 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Alleles at D6S265 and D6S105 define a haemochromatosis‐specific genotype

M. Worwood, A. Burnett, C. Darke, 1994, British journal of haematology.

GENE FREQUENCY AND LINKAGE DISEQUILIBRIUM ANALYSIS OF HLA‐DRB1*04 HAPLOTYPES IN A SOUTH WALES POPULATION

C. Darke, N. Young, 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Human leucocyte antigen polymorphisms in nut‐allergic patients in South Wales

C. Darke, B. Davies, J. Thompson, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Population screening for hemochromatosis by PCR using sequence-specific primers.

M. Worwood, C. Darke, M. Guttridge, 2000, Genetic testing.

Rapid Detection of Genetic Mutations Associated with Haemochromatosis

M. Worwood, C. Darke, M. Guttridge, 1998, Vox Sanguinis.

The frequency of the haemochromatosis‐associated genotype D6S265‐1:D6S105‐8 in blood donors

M. Worwood, Jennifer J. Pointon, C. Darke, 1996, British journal of haematology.

Serum ferritin, blood donation, iron stores and haemochromatosis

M. Worwood, C. Darke, 1993, Transfusion medicine.

HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians.

M. Brown, A. Milicic, Bryan Paul Wordsworth, 2002, The Journal of rheumatology.

Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.

C. Darke, A. E. Dolby, A. Amer, 2008, Tissue antigens.

Molecular, Serological and Population Studies of the Alleles and Products of HLA-B*41

C. Darke, M. Guttridge, M. Thomas, 1999, Experimental and Clinical Immunogenetics.

HLA-B*4703: sequence confirmation, serology and distribution.

C. Darke, M. Guttridge, M. Thomas, 1999, Tissue antigens.

Identification of HLA-A*0224: implications for PCR-SSP HLA typing.

C. Darke, M. Guttridge, M. Thomas, 1999, Tissue antigens.

Molecular, serological and population studies on a novel HLA-B allele--HLA-B*5002.

C. Darke, M. Guttridge, M. Thomas, 1998, Tissue antigens.

MHC-extended haplotypes in families of patients with Graves' disease.

S. Ratanachaiyavong, A. McGregor, C. Darke, 1993, Human immunology.

The HLA A1-B8 haplotype extends 6 Mb beyond HLA-A: associations between HLA-A, B, F and 15 microsatellite markers.

M. Worwood, Jennifer J. Pointon, K. Robson, 1997, Tissue antigens.

HLA class Iassociations ofankylosing spondylitis inthewhite population intheUnited Kingdom

M. Brown, A. Calin, L. Kennedy, 1996 .

Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia.

G. Owen, K. Mills, A. Burnett, 1995, Leukemia.

HLA and multiple sclerosis in south east Wales.

R. Swingler, D. Compston, C. Darke, 1987, Journal of neurology, neurosurgery, and psychiatry.

An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy.

D. Middleton, A. Maxwell, C. Patterson, 1998, Cytokine.

Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis.

L. Cardon, M. Brown, C. Meisel, 2008, Rheumatology.

TAP1 and TAP2 polymorphism in multiple sclerosis patients.

D. Middleton, D. Savage, S. Hawkins, 1994, Human immunology.

A new HLA-B44 variant (B44BO [B*4408]) identified by serology.

P. Parham, K. Arnett, C. Darke, 1997, Tissue antigens.

An evaluation of the ethidium bromide microcytotoxicity test.

C. Darke, E. Gay, 1974, Journal of immunological methods.

Prevalence of HLA‐DQA1 alleles and haplotypes in blood donors resident in Wales

C. Darke, A. J. Lemin, A. J. Lemin, 2014, International journal of immunogenetics.

Molecular characterization of the HLA-DR2LUM haplotype.

C. Darke, N. Young, 1994, Tissue antigens.

Association of HLA-Bw65 with two major complotypes.

C. Darke, G. O'Neill, 2008, Tissue antigens.

A LONG‐TERM FOLLOW‐UP OF POSTPARTUM THYROIDITIS

D. I. Phillips, J. Lazarus, A. Parkes, 1990, Clinical endocrinology.

Molecular, serological and genetic studies on two new HLA-DRB1 alleles--HLA-DRB1*0704 and HLA-DRB1*1507.

C. Darke, M. Guttridge, M. Thomas, 2000, Tissue antigens.

Human platelet antigens: typing by PCR using sequence-specific primers and their distribution in blood donors resident in Wales.

C. Darke, M. Guttridge, J. Thompson, 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Identification and nucleotide sequence of two novel DRB3 alleles, DRB3*0102 and DRB3*010133.

H. Williams, C. Darke, M. Guttridge, 1997, Tissue antigens.

The differentiation of HLA-B*1401 (B64) and B*1402 (B65) by the polymerase chain reaction using sequence-specific primers (PCR-SSP).

C. Darke, M. Guttridge, J. Thompson, 1995, Tissue antigens.

Allelic typing of the HLA-DR4 group by polymerase chain reaction--single-strand conformation polymorphism analysis.

C. Darke, N. Young, 1993, Human immunology.

HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.

G. Nuki, C. Darke, P. Dyer, 1983, British journal of diseases of the chest.

HLA-B*27:05:25 - a further HLA-B*27:05 allele with a synonymous nucleotide substitution.

C. Darke, M. Bengtsson, J. Street, 2014, Tissue antigens.

The HLA-B12 and -B40 cross-reactive groups and their serological relationships.

C. Darke, 2008, Tissue antigens.

Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity.

J. Lazarus, A. Parkes, C. Darke, 2000, The Journal of clinical endocrinology and metabolism.

Identification of a novel HLA-A allele (A*1115) in the UK National External Quality Assessment Schemes for Histocompatibility and Immunogenetics' Educational Cell Exchange.

C. Darke, P. Dunn, S. Corbin, 2006, Tissue antigens.

Discussion of the role of hemochromatosis susceptibility gene mutation in protecting against iron deficiency in celiac disease.

D. Ravine, C. Darke, 2003, Gastroenterology.

Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: a prospective study.

M. Ludgate, J. Lazarus, C. Darke, 1986, Journal of affective disorders.

Antigen Society #7 Report (B8, w59, B14, w64, w65)

F. Christiansen, R. Fauchet, R. Khan, 1989 .

Post-partum thyroid dysfunction.

A. Parkes, C. Darke, R. Hall, 1982, The New England journal of medicine.

The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis.

A. Calin, L. Kennedy, M. Brown, 2004, Arthritis and rheumatism.

Non-B27 MHC associations of ankylosing spondylitis

L. Bradbury, A. Calin, M. Brown, 2007, Genes and Immunity.

Frequency of HLA-DPB1 alleles, including a novel DPB1 sequence, in the Northern Ireland population.

D. Middleton, D. Savage, C. Darke, 1992, Human immunology.

Distribution of alleles at D6S105 and D6S265 with possible HLA haplotype associations.

M. Worwood, C. Darke, R. Raha-Chowdhury, 1994, Tissue antigens.

HLA class I (A, B) and II (DR, DQ) Gene and Haplotype Frequencies in Blood Donors from Wales

Mark George Thomas, C. Darke, M. Guttridge, 1998, Experimental and Clinical Immunogenetics.

Predicting cytomegalovirus disease after renal transplantation: an artificial neural network approach

D. McPhee, R. Moore, D. Sheppard, 1999, Int. J. Medical Informatics.

Severe Intravascular Haemolysis in a Renal Transplant Recipient due to Anti‐B of Donor Origin

J. Orchard, C. Darke, N. Young, 1990, Vox sanguinis.

HLA and TAP associations in Chinese systemic lupus erythematosus patients.

D. Savage, C. Darke, H. Howe, 1995, Tissue antigens.

An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision

C. Darke, 2000, Bone Marrow Transplantation.

Expression of MHC class I determinants on erythrocytes of SLE patients.

M. Walport, C. Darke, C. Giles, 1987, Clinical and experimental immunology.

A comparison of DNA-RFLP typing with serology and mixed lymphocyte reaction in the selection of matched unrelated bone marrow donors.

J. Bidwell, C. Darke, J. Harvey, 1989, Bone marrow transplantation.

A "silent" nucleotide substitution in exon 4 is responsible for the "alternative expression" of HLA-A*01:01:38L through aberrant splicing.

C. Darke, P. Dunn, J. Street, 2011, Human immunology.

Postpartum thyroid dysfunction and HLA status

C. Darke, R. Hall, M. Koloğlu, 1990, European journal of clinical investigation.

Remission of post-transfusion thrombocytopenic purpura with high dose intravenous corticosteroids.

P. Gerrish, M. Mir, C. Darke, 2008, Clinical and laboratory haematology.

Sequence, genetics and serology of a new HLA-B allele: B*4903.

C. Darke, M. Guttridge, J. Street, 2001, Tissue antigens.

Prediction of outcome in Graves' disease after carbimazole treatment.

S. Ratanachaiyavong, A. Weetman, J. Lazarus, 1986, The Quarterly journal of medicine.

A group‐specific sequence‐based typing approach for HLA‐DQA1

C. Darke, J. Johnson, A. J. Lemin, 2015, International journal of immunogenetics.

GENOMIC ANALYSIS OF THE F SUBTYPES OF HUMAN COMPLEMENT FACTOR B

C. Darke, G. Hauptmann, G. Geserick, 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype.

D. Kwiatkowski, M. Brown, J. Newton, 2003, Arthritis and rheumatism.

A novel HLA‐B*40 sequence – B*40:92

C. Darke, J. Street, L. Hammond, 2011, International journal of immunogenetics.

HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.

C. Darke, M. Rees, 2003, Transplant immunology.

Production of an HLA-DRw13 antibody in a DRw14 positive multiparous woman.

C. Darke, J. Street, 2008, Tissue antigens.

Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia.

K. Mills, A. Burnett, C. Darke, 1999, Blood.

"Molecular crossmatching" for allogeneic bone marrow transplants by DNA single-strand polymorphism analysis

C. Darke, N. Young, 1993, The Lancet.

Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis.

D. Kwiatkowski, M. Brown, K. Rockett, 2004, Arthritis and rheumatism.

Immunogenetics of a new HLA-B null allele, HLA-B*4423N.

C. Darke, J. Downing, J. Street, 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

A miniaturised method for immunoglobulin allotype serology.

C. Darke, N. Young, J. Street, 1989, Journal of immunological methods.

Analysis of the distribution of HLA-B alleles in populations from five continents.

D Middleton, A. Daar, M. Hammond, 2000, Human immunology.

The first example of an HLA-Bw45 antiserum produced in a HLA-Bw44 positive woman.

C. Darke, 2008, Tissue antigens.

The use of the IgG fraction of typing sera in the lymphocytotoxic test: a comparison with other cytotoxic methods.

C. Darke, W. N. Perry, 1976, Journal of immunological methods.

Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment.

P Wordsworth, A Calin, Paul Wordsworth, 1997, Arthritis and rheumatism.

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

A Calin, A. Calin, L. Kennedy, 1996, Annals of the rheumatic diseases.

HLA-A*24020102L in the UK blood donor population.

C. Navarrete, C. Darke, P. Dunn, 2004, Tissue antigens.

Meeting Report 16 th IHIW : Analysis of HLA Population Data , with updated results for 1996 to 2012 workshop data ( AHPD project report )

M. Currat, F. Poli, C. Vangenot, 2012 .

Immunogenetics of the rare HLA-B allele B*4408.

C. Darke, J. Downing, J. Street, 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Provision of Epstein-Barr virus-transformed B-cell lines in a routine tissue typing laboratory: practicalities and applications.

C. Darke, R. Walters, H. Bass, 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Identification, sequencing and serology of HLA-B*3527.

C. Darke, M. Guttridge, J. Street, 1999, Tissue antigens.

HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al.

Paul Wordsworth, A. Calin, C. Darke, 1996, Arthritis and rheumatism.

HLA‐B*15:33, a rare allele whose product reacts as an HLA‐B62 and ‐Cw5/Cw8 specificity

C Darke, C. Darke, J Street, 2012, International journal of immunogenetics.

Immunogenetic study of a new HLA allele, B*2723.

C. Darke, J. Downing, J. Street, 2002, Tissue antigens.

Immunogenetics of two new HLA-B alleles: B*4414 and B*5708.

C. Darke, J. Downing, J. Street, 2003, Tissue antigens.

Observations on the HLA-A2403 specificity.

C. Darke, J. Downing, J. Street, 2003, Tissue antigens.

Immunogenetics of two new HLA alleles: A*0108 and B*4031.

C. Darke, J. Downing, J. Street, 2003, Tissue antigens.

Improved efficiency of EBV transformation of B‐lymphocytes

C. Darke, H. Bass, 2004, Cell Proliferation.

HLA class I and H ferritin gene polymorphisms in normal subjects and patients with haemochromatosis

M. Worwood, C. Darke, S. Cragg, 1988, Human Genetics.

HLA gene and haplotype frequencies in Russians, Bashkirs and Tatars, living in the Chelyabinsk Region (Russian South Urals)

C. Darke, T. Suslova, M. N. Vavilov, 2012, International journal of immunogenetics.

Incidence and clinical significance of HLA-DP patient-donor mismatches in allogeneic bone marrow transplantation.

G. M. Taylor, C. Darke, W. Howell, 1995, Bone Marrow Transplantation.

HLAandmultiple sclerosis insouth eastWales

C. Darke, FromtheDepartment ofNeurology, P. Kirk, 1987 .

Significance of HL-A cytotoxic antibodies in Rh haemolytic disease.

C. Darke, I. Fraser, G. Tovey, 1970, Lancet.

The HLA‐C*05 family allele – C*05:142

C. Darke, J. Rowlands, C. Harvey, 2017, International Journal of Immunogenetics.

A novel HLA‐B*14 allele – B*14:53 – genetics and serology

C. Darke, C. Darke, E. Davies, 2016, International journal of immunogenetics.

A reanalysis of the HLA-B7 cross-reactive group.

C. Darke, 2008, Tissue antigens.

Spontaneous lymphocyte proliferation in severe periodontal disease: role of T and B cells.

C. Darke, A. E. Dolby, A. Amer, 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

HLA-A and B antigen frequencies in Welsh coalworkers with pneumoconiosis and Caplan's syndrome.

C. Darke, M. M. Wagner, 2008, Tissue antigens.

Hereditary haemochromatosis and blood donation.

M. Worwood, C. Darke, P. Trenchard, 1991, BMJ.

HLA gene and haplotype frequencies in a Nagaybaks population from the Chelyabinsk Region (Russian South Urals).

C. Darke, T. Suslova, M. N. Vavilov, 2017, Human Immunology.

HLA-A*26:92-a further allele possessing a segment of A*02:01:01:01.

C. Darke, J. Street, J. Pepperall, 2013, Tissue antigens.

A new HLA-A*03 null allele - A*03:162N caused by an exon 4 insertion and discovered during an external quality assessment exercise.

C. Darke, M. Bengtsson, S. Corbin, 2014, Tissue antigens.

16th IHIW: Analysis of HLA Population Data, with updated results for 1996 to 2012 workshop data (AHPD project report)

M. Lokki, T. Jaatinen, A. Wennerström, 2012, International journal of immunogenetics.